There is no more rigorous or accurate benchmarking resource for provider compensation planning. Our surveys offer market-specific data composed of compensation, production, and benefits information ...
The industry’s only compensation survey dedicated to understanding the unique data needs of the pediatric market. Our survey provides an in-depth review of pediatric subspecialty market trends, ...
There is no more rigorous or accurate benchmarking resource for academic provider compensation planning.Our faculty survey offers market-specific compensation, production, and benefits information ...
Case Studies
A HEALTH SYSTEM initiated a master facility plan (MFP) development process and, in response to market pressure, wanted to define an ASC strategy to prevent leakage of case volume
ECG PARTNERED WITH an approximately 715-bed health system with two acute care hospitals. The system offers a broad range of healthcare services and supports a variety of community
Articles
As more health systems recognize the need to create a more substantial ambulatory surgery capability, executives should explore ASC joint ventures with employed surgeons.
Blog
In search of value, payers want to redefine the role that PCPs play in patient care.
Service Line Strategy
Ongoing pressures, intensified by COVID-19, are forcing oncology providers to transform existing cancer care models.
Oncology is a unique and dynamic segment of the US healthcare system. The complexity of the associated diseases, pace of innovation, and myriad treatment options can leave providers struggling to keep up. This clinical and technological innovation comes at a cost, approaching $100 billion annually; as a result, affordability has become a major concern for patients, legislators, and providers alike.
Oncology providers are under pressure to find cost-control measures that ensure patients can afford the care they need while keeping cancer programs financially viable. The recent COVID-19 pandemic has intensified these issues, exposing flaws in the current operating model and accelerating innovation efforts. Oncology providers have significant challenges to overcome as they adapt business and operational practices in search of long-term sustainability.
Download the Oncology Services Brochure
Principal, Washington D.C.
Principal, Seattle
Associate Principal, Dallas
Senior Manager, Washington D.C.
Manager, Seattle
Manager, Boston
Congress further delayed the Radiation Oncology (RO) Model, which is now expected to begin January 1, 2022. Participants can use this extra time to their advantage.
The new mandatory payment model is intended to align Medicare’s payments for Part B drugs with prices offered internationally for the same drugs, as well as remove incentives to unnecessarily use higher-cost drugs.
As payers move to restrict hospital-based imaging, here are 6 recommendations to help hospitals mitigate near-term losses and diversify their imaging portfolios.
Explore the anticipated impact of the proposed CMS changes to the MPFS for CY 2021 to avoid possible financial losses for your organization.
We have received your request and will be in touch shortly.
Choose All That Apply